Your browser doesn't support javascript.
loading
p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.
Genders, Roel E; Beck, Samuel; Bouwes Bavinck, Jan Nico; van den Munckhof, Henk A M; Kouwenhoven, Stijn T P; de Koning, Maurits N C; de Gruijl, Frank R; Jenkins, David; Willemze, Rein; Quint, Koen D.
Afiliação
  • Genders RE; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Beck S; Department of Dermatology, Roosevelt Clinics, Leiden, The Netherlands.
  • Bouwes Bavinck JN; DDL Diagnostic Laboratory, Rijswijk, the Netherlands.
  • van den Munckhof HA; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Kouwenhoven ST; DDL Diagnostic Laboratory, Rijswijk, the Netherlands.
  • de Koning MN; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • de Gruijl FR; DDL Diagnostic Laboratory, Rijswijk, the Netherlands.
  • Jenkins D; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Willemze R; DDL Diagnostic Laboratory, Rijswijk, the Netherlands.
  • Quint KD; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
J Cutan Pathol ; 44(1): 28-33, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27717097
ABSTRACT

BACKGROUND:

For selecting therapy, it is important to distinguish different types of keratinocytic neoplasia. It is sometimes difficult to make histopathologic diagnosis, especially in organ transplant recipients (OTR) who develop numerous lesions.

METHODS:

To investigate p16 immunostaining in different types of keratinocytic neoplasia in OTR, we studied 59 actinic keratoses (AK), 51 Bowen' s disease (BD), 63 squamous cell carcinomas (SCC), 16 benign keratotic lesions (BKL) from 31 OTR patients and 25 controls (eczema and psoriasis). Tissue sections were stained for H&E and p16. We scored intensity, proportion and distribution of p16 positive lesional cells.

RESULTS:

In 19% of AK, 92% of BD, 35% of SCC and 12% of BKL more than 15% of lesional cells were p16-positive. In 16% of AK, 80% of BD, 18% of SCC and 13% of BKL strong p16 staining was observed. BKL, AK and SCC showed focal and patchy staining, BD showed diffuse pattern with strong staining of all atypical cells. Sparing of the basal layer was predominantly seen in BD. No control specimen showed p16-overexpression.

CONCLUSIONS:

p16 immunostaining shows a characteristic pattern in BD, but not in AK, SCC and BKL. It appears useful in recognizing BD, but not in differentiating between other keratinocytic neoplasia.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Doença de Bowen / Inibidor p16 de Quinase Dependente de Ciclina Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Doença de Bowen / Inibidor p16 de Quinase Dependente de Ciclina Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article